Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 391

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 391
---
10-Q
     
    001-14895
     
    10.1
     
    5/8/19

     10.43†
     
    Form of Executive Vice President Severance Letter Agreement
     
    10-Q
     
    001-14895
     
    10.2
     
    5/8/19

     10.44†
     
    Form of Executive Vice President Change in Control and Severance Agreement 
     
    10-Q
     
    001-14895
     
    10.3
     
    5/8/19

     10.45^
     
    License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd dated December 21, 2019
     
    10-K
     
     001-14895
     
    10.51
     
    2/26/20

     10.46†
     
    Director Compensation Policy
     
    10-K
     
     001-14895
     
    10.55
     
    2/26/20

     10.47†
     
    Amendment No. 2 to the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan
     
    8-K
     
    001-14895
     
    10.1
     
    2/21/20

     10.48†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    8-K
     
    001-14895
     
    10.1
     
    6/8/2020

     10.49†
     
    Amendment No. 2 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.1
     
    8/2/2022

     10.50†
     
    Promotion Letter dated December 14, 2020 by and between Sarepta Therapeutics, Inc. and Louise Rodino-Klap